AAPS Open

Table 1 Demographic and baseline characteristics of participants (safety, pharmacokinetic, and statistical datasets)

From: Relative bioavailability of diazoxide, manufactured at two different international locations, in healthy participants under fasting conditions: an open-label, two-stage, adaptive, sequential two-period crossover study

	N = 36
Age (years), mean ± SD	41 ± 10
Age group, n (%)
18–40 years	17 (47.2)
41–64 years	19 (52.8)
Sex, n (%)
Male	17 (47.2)
Female	19 (52.8)
Race, n (%)
Asian	10 (27.8)
Black	8 (22.2)
White	18 (50.0)
Ethnicity, n (%)
Hispanic/Latino	3 (8.3)
BMI (kg/m²), mean ± SD	25.6 ± 2.4
Height (cm), mean ± SD	168.1 ± 8.7
Weight (kg), mean ± SD	72.7 ± 11.5

BMI body mass index, SD standard deviation

Back to article page